Mon-Li Chu Selected Research

recessive Cutis laxa

5/2017	Fibulin-4 is essential for maintaining arterial wall integrity in conduit but not muscular arteries.
8/2015	Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril Abnormalities.
4/2003	Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mon-Li Chu Research Topics

Disease

6	Scleroatonic muscular dystrophy 04/2014 - 11/2002
5	Contracture 06/2016 - 08/2003
4	Muscle Weakness 04/2014 - 08/2003
4	Muscular Dystrophies (Muscular Dystrophy) 02/2014 - 02/2008
3	recessive Cutis laxa 05/2017 - 04/2003
3	Fibrosis (Cirrhosis) 01/2016 - 10/2003
3	Myocardial Infarction 01/2016 - 01/2012
3	Ventricular Dysfunction 01/2016 - 01/2012
3	Bethlem myopathy 04/2014 - 11/2002
3	Neoplasms (Cancer) 08/2011 - 02/2002
3	Cutis Laxa 11/2007 - 04/2003
2	Wounds and Injuries (Trauma) 06/2014 - 02/2014
2	Muscular Diseases (Myopathy) 04/2014 - 02/2014
2	Infarction (Infarctions) 01/2012 - 10/2003
1	Aortic Aneurysm (Aneurysm, Aortic) 05/2017
1	Cardiovascular Abnormalities 05/2017
1	Hypertension (High Blood Pressure) 01/2016
1	Hypertrophy 01/2016
1	Blister (Bulla) 06/2014
1	Cardiomegaly (Heart Hypertrophy) 02/2014
1	Adenocarcinoma 01/2014
1	Protein Deficiency 05/2013
1	Heart Rupture 01/2012
1	Ventricular Remodeling 01/2012
1	Neoplasms, Cystic, Mucinous, and Serous 08/2011
1	Cystadenoma 08/2011
1	Vascular System Injuries 01/2010
1	Thrombosis (Thrombus) 01/2010
1	Aneuploidy (Aneuploid) 10/2007
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 03/2004
1	Body Weight (Weight, Body) 10/2003
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2003

Drug/Important Bio-Agent (IBA)

14	CollagenIBA 06/2016 - 11/2002
5	fibulin 2IBA 01/2016 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2002
2	ElastinIBA 05/2017 - 04/2003
2	Collagen Type I (Type I Collagen)IBA 01/2016 - 01/2014
2	Angiotensin IIIBA 01/2016 - 02/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 04/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016 - 02/2014
2	Collagen Type VIIBA 01/2014 - 11/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	IntegrinsIBA 06/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 02/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2011
1	Fibrillar CollagensIBA 08/2011
1	Nonsense Codon (Nonsense Mutation)IBA 03/2010
1	Thromboplastin (Tissue Factor)IBA 01/2010
1	AgarIBA 10/2007
1	Extracellular Matrix ProteinsIBA 10/2007
1	Biological ProductsIBA 03/2004
1	salicylhydroxamic acid (SHAM)IBA 10/2003
1	Amino Acids FDA Link 08/2003

Therapy/Procedure

2	Ligation 01/2010 - 10/2003
1	Therapeutics 02/2014
1	Stem Cell Transplantation 02/2014